MGIM
BRNS

M&G Investment Management’s Barinthus Biotherapeutics BRNS Stock Holding History

M&G Investment Management’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$20.8M Hold
5,197,349
– – 0.07% 122
2023
Q3 		$15.6M Hold
5,197,349
– – 0.07% 149
2023
Q2 		$10.4M Hold
5,197,349
– – 0.04% 198
2023
Q1 		$10.4M Hold
5,197,349
– – 0.05% 180
2022
Q4 		$10.4M Hold
5,197,349
– – 0.05% 175
2022
Q3 		$15.6K Buy
5,197,349
+4,108,752
+377% +$17.4M 0.09% 140
2022
Q2 		$4.35K Hold
1,088,597
– – 0.03% 256
2022
Q1 		$5.44K Hold
1,088,597
– – 0.01% 247
2021
Q4 		$12K Hold
1,088,597
– – 0.03% 186
2021
Q3 		$17.4K Hold
1,088,597
– – 0.04% 216
2021
Q2 		$18.5K Buy
+1,088,597
New +$16.1M 0.05% 200

Other funds holding BRNS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.06B AUM 20.01% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
JHU
Johns Hopkins University Baltimore, Maryland $1.38B AUM 9.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IIM
Ipswich Investment Management Beverly, Massachusetts $426M AUM 24.58% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return